Shiga-toxin producing Escherichia coli and the hemolytic uremic syndrome: what have we learned in the past 25 years?

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Advances in Experimental Medicine and Biology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/978-0-387-79838-7_1PMID 19280844
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Escherichia coli 0157 : H 7 Diarrhea in the United States : Clinical and Epidemiologic Features

  2009cited by this paper
• Preventing household transmission of Shiga toxin-producing Escherichia coli O157 infection: promptly separating siblings might be the key.

  2008cited by this paper
• Isolation of patients acutely infected with Escherichia coli O157:H7: low-tech, highly effective prevention of hemolytic uremic syndrome.

  2008cited by this paper
• Rapid Detection of Shiga Toxin-Producing Escherichia coli by Optical Immunoassay

  2007influential reference
• Summary of notifiable diseases --- United States, 2005.

  2007cited by this paper
• Characterization of Shiga Toxin-Producing Escherichia coli Isolates Associated with Two Multistate Food-Borne Outbreaks That Occurred in 2006

  2007cited by this paper
• Normotensive ischemic acute renal failure.

  2007cited by this paper
• Shiga Toxin-Mediated Hemolytic Uremic Syndrome: Time to Change the Diagnostic Paradigm?

  2007cited by this paper
• Strategies to reduce person-to-person transmission during widespread Escherichia coli O157:H7 outbreak.

  2007cited by this paper
• Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome.

  2005cited by this paper
• Relative Nephroprotection During Escherichia coli O157:H7 Infections: Association With Intravenous Volume Expansion

  2005cited by this paper
• Non-O157 Shiga toxin-producing Escherichia coli infections in the United States, 1983-2002.

  2005cited by this paper
• Response to Shiga toxin 1 and 2 in a baboon model of hemolytic uremic syndrome

  2003cited by this paper
• Comparison of a Commercial Reversed Passive Latex Agglutination Assay to an Enzyme Immunoassay for the Detection of Shiga Toxin-Producing Escherichia coli

  2003cited by this paper
• Shiga toxin receptor glycolipid binding. Pathology and utility.

  2003cited by this paper
• Long-term renal prognosis of diarrhea-associated hemolytic uremic syndrome: a systematic review, meta-analysis, and meta-regression.

  2003cited by this paper
• Critical Roles for stx2,eae, and tir in EnterohemorrhagicEscherichia coli-Induced Diarrhea and Intestinal Inflammation in Infant Rabbits

  2003cited by this paper
• Shiga toxin-producing Escherichia coli in Montana: bacterial genotypes and clinical profiles.

  2003cited by this paper
• Evaluation of the Duopath Verotoxin Test for Detection of Shiga Toxins in Cultures of Human Stools

  2003cited by this paper
• An outbreak of Escherichia coli O157 infection following exposure to a contaminated building.

  2003cited by this paper
• [PulseNet Japan--network system for the utilization of epidemiological information and the results of pulsed-field gel electrophoresis].

  2002cited by this paper
• Population-based trends in pediatric hemolytic uremic syndrome in California, 1994-1999: substantial underreporting and public health implications.

  2002cited by this paper
• Escherichia coli O157:H7 infections: discordance between filterable fecal shiga toxin and disease outcome.

  2002cited by this paper
• Risk of hemolytic uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 enteritis: a meta-analysis.

  2002cited by this paper
• Prothrombotic coagulation abnormalities preceding the hemolytic-uremic syndrome.

  2002influential reference
• Shiga toxin-producing Escherichia coli in children with diarrhea: a prospective point-of-care study.

  2002influential reference
• An outbreak of Escherichia coli O157:H7 infections among visitors to a dairy farm.

  2002cited by this paper
• Contact with farming environment as a major risk factor for Shiga toxin (Vero cytotoxin)-producing Escherichia coli O157 infection in humans.

  2001cited by this paper
• The central Scotland Escherichia coli O157:H7 outbreak: risk factors for the hemolytic uremic syndrome and death among hospitalized patients.

  2001cited by this paper
• Pathogenesis of Shiga Toxin-Associated Hemolytic Uremic Syndrome

  2001cited by this paper
• Von Willebrand Factor and Von Willebrand Factor-Cleaving Metalloprotease Activity in Escherichia coli O157:H7-Associated Hemolytic Uremic Syndrome

  2001cited by this paper
• Molecular characterization of Mycobacterium abscessus strains isolated from a hospital outbreak.

  2000cited by this paper
• The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections.

  2000cited by this paper
• Induction of type 2 Shiga toxin synthesis in Escherichia coli O157 by 4-quinolones.

  1999cited by this paper
• Massive outbreak of Escherichia coli O157:H7 infection in schoolchildren in Sakai City, Japan, associated with consumption of white radish sprouts.

  1999cited by this paper
• Apoptosis of Renal Cortical Cells in the Hemolytic-Uremic Syndrome: In Vivo and In Vitro Studies

  1998cited by this paper
• An outbreak of Escherichia coli O157:H7 infections associated with leaf lettuce consumption.

  1998cited by this paper
• Verotoxins induce apoptosis in human renal tubular epithelium derived cells.

  1998cited by this paper
• Risk of hemolytic uremic syndrome after sporadic Escherichia coli O157:H7 infection: results of a Canadian collaborative study. Investigators of the Canadian Pediatric Kidney Disease Research Center.

  1998cited by this paper
• Strain-Specific Differences in the Amount of Shiga Toxin Released from Enterohemorrhagic Escherichia coli O157 following Exposure to Subinhibitory Concentrations of Antimicrobial Agents

  1998cited by this paper
• Cholelithiasis following Escherichia coli O157 : H7-associated hemolytic uremic syndrome

  1998cited by this paper
• Predictors of hemolytic uremic syndrome in children during a large outbreak of Escherichia coli O157:H7 infections.

  1997influential reference
• Delays in the diagnosis of oesophagogastric cancer: a consecutive case series

  1997cited by this paper
• A prolonged outbreak of Escherichia coli O157:H7 infections caused by commercially distributed raw milk.

  1997cited by this paper
• An outbreak of Escherichia coli O157:H7 infections traced to jerky made from deer meat.

  1997cited by this paper
• Summary of Notifiable Diseases, United States.

  1997cited by this paper
• An outbreak of Escherichia coli O157:H7 infections traced to jerky made from deer meat.

  1997cited by this paper
• A new route of transmission for Escherichia coli: infection from dry fermented salami.

  1996cited by this paper
• Escherichia coli verotoxin binding to human paediatric glomerular mesangial cells

  1995cited by this paper
• Verotoxin-binding in human renal sections.

  1994cited by this paper
• A swimming-associated outbreak of hemorrhagic colitis caused by Escherichia coli O157:H7 and Shigella sonnei.

  1994cited by this paper
• A multistate outbreak of Escherichia coli O157:H7-associated bloody diarrhea and hemolytic uremic syndrome from hamburgers. The Washington experience.

  1994cited by this paper
• Racial incidence of hemolytic uremic syndrome

  1994cited by this paper
• Impairment by verotoxin of tubular function contributes to the renal damage seen in haemolytic uraemic syndrome.

  1993cited by this paper
• An outbreak of diarrhea and hemolytic uremic syndrome from Escherichia coli O157:H7 in fresh-pressed apple cider.

  1993cited by this paper
• Physical map location of the rpoN gene of Escherichia coli

  1993cited by this paper
• A Waterborne Outbreak in Missouri of Escherichia coli O157:H7 Associated with Bloody Diarrhea and Death

  1992cited by this paper
• Long-term outcome and prognostic indicators in the hemolytic-uremic syndrome.

  1991cited by this paper
• Report of the Committee on Infectious Diseases

  1989cited by this paper
• Infections with Escherichia coli O157:H7 in Washington State. The first year of statewide disease surveillance.

  1989cited by this paper
• Hemolytic uremic syndrome and diarrhea in Argentine children: the role of Shiga-like toxins.

  1989cited by this paper
• Verotoxin receptor glycolipid in human renal tissue.

  1989cited by this paper
• Epidemiology of sporadic diarrhea due to verocytotoxin-producing Escherichia coli: a two-year prospective study.

  1988cited by this paper
• Site of action of a Vero toxin (VT2) from Escherichia coli O157:H7 and of Shiga toxin on eukaryotic ribosomes. RNA N-glycosidase activity of the toxins.

  1988cited by this paper
• Hemolytic uremic syndrome epidemiology: a population-based study in King County, Washington, 1971 to 1980.

  1987cited by this paper
• Sorbitol-MacConkey medium for detection of Escherichia coli O157:H7 associated with hemorrhagic colitis

  1986cited by this paper
• ESCHERICHIA COLI 0157:H7 STRAINS ASSOCIATED WITH HAEMORRHAGIC COLITIS IN THE UNITED STATES PRODUCE A SHIGELLA DYSENTERIAE 1 (SHIGA) LIKE CYTOTOXIN

  1983cited by this paper
• Hemorrhagic colitis associated with a rare Escherichia coli serotype.

  1983cited by this paper
• Sporadic cases of haemolytic-uraemic syndrome associated with faecal cytotoxin and cytotoxin-producing Escherichia coli in stools.

  1983cited by this paper
• Hemorrhagic colitis associated with a rare Escherichia coli serotype

  1983cited by this paper
• The importance of nonrenal involvement in hemolytic-uremic syndrome.

  1980cited by this paper
• Hemolytic uremic syndrome in families.

  1975cited by this paper
• Letter: How blind is the double-blind?: an assessment in a lithium-prophylaxis study.

  1974cited by this paper
• Hämolytisch-urämische Syndrome im Kindesalter

  1956cited by this paper

• A Multi-Specific DARPin Potently Neutralizes Shiga Toxin 2 via Simultaneous Modulation of Both Toxin Subunits

  2022cites this paper
• Hydration in hemolytic uremic syndrome.

  2021cites this paper
• Shiga toxin-producing Escherichia coli associated hemolytic uremic syndrome (STEC-HUS)

  2020cites this paper
• Pharmacokinetic and Pharmacodynamic Considerations for the Use of Monoclonal Antibodies in the Treatment of Bacterial Infections

  2018cites this paper
• Case definitions of hemolytic uremic syndrome following Escherichia coli O157:H7 infection vary in validity.

  2018cites this paper
• Early Volume Expansion and Outcomes of Hemolytic Uremic Syndrome

  2017cites this paper
• Escherichia coli O157:H7 Phylogenetics: Implications for Virulence and Disease Distribution

  2017cites this paper
• Emerging Risk evaluation of Enterohaemorrhagic Escherichia coli on Public Health

  2016cites this paper
• Protective Efficacy and Pharmacokinetics of Human/Mouse Chimeric Anti-Stx1 and Anti-Stx2 Antibodies in Mice

  2015cites this paper
• Protective efficacy and pharmacokinetics of human/mouse chimeric anti-Stx1 and anti- 1

  2015cites this paper
• Treatment of Shiga toxin-producing Escherichia coli infections.

  2013cites this paper
• Recent Advances in Understanding Enteric Pathogenic Escherichia coli

  2013cites this paper
• Lactic acid resistance of Shiga toxin-producing Escherichia coli and multidrug-resistant and susceptible Salmonella Typhimurium and Salmonella Newport in meat homogenate.

  2013cites this paper
• Biofilm formation of O157 and non-O157 Shiga toxin-producing Escherichia coli and multidrug-resistant and susceptible Salmonella typhimurium and newport and their inactivation by sanitizers.

  2013cites this paper
• Shiga Toxin Pathogenesis: Kidney Complications and Renal Failure

  2013cites this paper
• Recommendations for Diagnosis of Shiga Toxin-- Producing Escherichia coli Infections by Clinical Laboratories

  2012cites this paper
• Shiga toxin pathogenesis: kidney complications and renal failure.

  2012cites this paper
• Early volume expansion during diarrhea and relative nephroprotection during subsequent hemolytic uremic syndrome.

  2011cites this paper
• Prevalence of Stx Phages in Environments of a Pig Farm and Lysogenic Infection of the Field E. coli O157 Isolates with a Recombinant Converting Phage

  2011cites this paper
• Human Intestinal Tissue and Cultured Colonic Cells Contain Globotriaosylceramide Synthase mRNA and the Alternate Shiga Toxin Receptor Globotetraosylceramide

  2010cites this paper
• Treatment of Typical (Enteropathic) Hemolytic Uremic Syndrome

  2010influential citation
• Treatment of typical (enteropathic) hemolytic uremic syndrome.

  2010influential citation
• Zoonotic enterohemorrhagic Escherichia coli: A One Health perspective.

  2010influential citation